What we do
Equity products
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
Pan-European Venture Capital Fund(s)-of-Funds programme
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
Debt products
AGRI Guarantee Facility
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
EREM debt products
Single EU Debt Financial Instrument
COSME - Loan Guarantee Facility
InnovFin SME Guarantee Facility
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
Baltic Innovation Fund (BIF)
Competitiveness Fund-of-Funds for SMEs in Romania
Regional Fund-of-Funds Romania
La Financière Région Réunion
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
Dutch Venture Initiative (DVI-II)
Dutch Growth Co-Investment Programme
European Recovery Programme (ERP)
ERP-EIF Co-Investment Growth Facility
ESIF Fund-of-Funds Czech Republic
ESIF Fund-of-Funds Greece
The Silesia EIF Fund of Funds
EstFund
FOSTER TPE-PME Occitanie
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
JEREMIE
LfA-EIF Facility
Luxembourg Future Fund (LFF)
Mezzanine 'Fund of Fund' for Germany (MDD)
Polish Growth Fund of Funds (PGFF)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
The EIB Group Risk Enhancement Mandate (EREM)
Western Balkans Enterprise Development & Innovation Facility II (WB EDIF II)

UniCredit Bank (Austria)

image

Zeta Biopharma is a plant construction company in Austria with 237 employees providing process technology for biopharmaceutical applications by supplying global pharmaceutical companies with individually designed plants.

Zeta’s production plants are used by large pharma companies to develop vaccines, injections and pharmaceutical drugs used to fight diseases worldwide. The company is one of only two in Europe to use freeze and thaw containers for storage and transport of substances for the pharmaceutical industry. These liquids can be frozen in a controller storage facility for years and are often sent to markets worldwide.

The plants are manufactured in modular design with state-of-the-art equipment at the production site in Lieboch, Graz, and are dispatched to operation sites across Europe and beyond under sterile conditions  where they are then installed and commissioned by qualified staff and engineers.

UniCredit Bank Austria is the leading bank in Austria and Central and Eastern Europe. The bank has been a member of UniCredit since 2005. Bank Austria is an EIF partner under the Risk Sharing Initiative (RSI) thanks to its SME strategy, financial standing, risk models, origination power, marketing initiatives and proved, in particular its know-how in export- and investment promotion funding and advisory. During the financial and economic crisis, Bank Austria was the only major bank in Austria that did not use state aid to strengthen its capital. Bank Austria supports Austria’s economy by providing special offers for innovative SMEs – from advisory services in the start-up phase to financing solutions including funding all the way to business planning and succession planning.

The EUR 2,5m working capital loan granted by UniCredit Bank Austria with a 50% EIF guarantee under the RSI covers Zeta’s high working capital requirements during the long lead times in plant engineering and manufacturing. The RSI guarantee funded by the EU Commission and the EIB perfectly complements the national research promotion schemes in Austria and helps the company to implement additional R&D projects and to achieve faster growth.

  • Company: Zeta Biopharma, Austria
  • Type of business: plant construction company
  • EU-supported loan through UniCredit Bank Austria:  EUR 2,5m

For further information about EIF intermediaries in Austria, please refer to:
http://www.eif.org/what_we_do/where/at


 
 

Copyright ©

 European Investment Fund 2017 – The European Investment Fund is not responsible for the content of external internet sites.